Univariate analysis for determining differences in patients with cardioembolic occlusion in comparison with patients with carotid embolic occlusions
| Variable | Cardioembolic/cryptogenic | Carotid embolic (n=157) | p Value (n=50) |
| Age (mean±SD) (years) | 71±11 | 65±10 | 0.001 |
| Female sex (N (%)) | 71 (45) | 24 (48) | 0.45 |
| NIHSS | 18±5 | 15±4 | 0.01 |
| Diabetes mellitus (N (%)) | 36 (23) | 14 (28) | 0.45 |
| Hypertension (N (%)) | 98 (62) | 32 (64) | 0.87 |
| Hyperlipidemia (N (%)) | 36 (23) | 13 (26) | 0.70 |
| Intravenous t-PA (N (%)) | 48 (31) | 13 (26) | 0.59 |
| Time to treatment (min±SD) | 300±85 | 325±105 | 0.72 |
| Mechanical thrombectomy (N (%)) | 94 (60) | 23 (46) | 0.10 |
| Stent placement (N (%)) | 21 (13) | 41 (82) | 0.001 |
| Glycoprotein IIb/IIIa inhibitor (N (%)) | 57 (36) | 42 (84) | 0.001 |
| Multimodal therapy (N (%)) | 105 (67) | 48 (96) | 0.001 |
| Intra-arterial t-PA (N (%)) | 106 (68) | 28 (56) | 0.62 |
| TIMI 2/3 (N (%)) | 94 (60) | 43 (86) | 0.001 |
| Carotid terminus occlusion (N (%)) | 57 (36) | 7 (14) | 0.003 |
| Symptomatic ICH (N (%)) | 16 (10) | 6 (12) | 0.79 |
| Asymptomatic ICH (N (%)) | 55 (35) | 12 (24) | 0.17 |
NIHSS, National Institutes of Health Stroke Scale; t-PA, tissue plasminogen activator.